<div class="p4l_caption"><div class="p4l_captionTitle"><a target="_blank" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4110025/" ref="ordinalpos=4751&amp;ncbi_uid=6425535&amp;link_uid=PMC4110025" image-link="/pmc/articles/PMC4110025/figure/pone-0103440-g001/" class="imagepopup">Figure 1. Effects of HPV-16 oncoproteins on HIF-1α expression and PI3K/Akt/mTOR <span class="highlight" style="background-color:">signaling</span> <span class="highlight" style="background-color:">pathway</span> activation in NSCLC cells..  From: Roles of PI3K/Akt and c-Jun <span class="highlight" style="background-color:">Signaling</span> Pathways in Human Papillomavirus Type 16 Oncoprotein-Induced HIF-1?, VEGF, and IL-8 Expression and In Vitro Angiogenesis in Non-Small Cell Lung Cancer Cells. </a></div><br /><div class="p4l_captionBody">(A) Western blot analysis of HIF-1α protein levels in stable-transfected A549 cells. (B) Real-time PCR analysis of HIF-1α mRNA levels in stable-transfected A549 cells. (C and D) Western blot analysis of p-Akt, p-P70S6K, p-P85S6K, and p-mTOR protein levels in transfected A549 (C) and NCI-H460 (D) cells.</div></div>